Form 8-K · Current report
Charles Schwab Corporation 8-K, filed Aug 12, 2026
- Filed
- CIK
- 0000316709
- Accession no.
- 0001193125-26-347083
Summary
The Charles Schwab Corporation issued $1.25 billion of 5.108% fixed-to-floating rate senior notes due 2032 and $1.35 billion of 5.655% fixed-to-floating rate senior notes due 2037, raising net proceeds of about $2.582 billion after underwriting discounts and estimated offering expenses. The notes were sold to underwriters represented by BofA Securities, Citigroup Global Markets, Morgan Stanley, TD Securities (USA) and Wells Fargo Securities under an underwriting agreement dated August 10, 2026.
Key points
- Schwab issued the notes on August 12, 2026 under a senior indenture with The Bank of New York Mellon Trust Company as trustee, supplemented by a fourth supplemental indenture.
- The offering was made under Schwab's effective Form S-3 registration statement via a prospectus supplement dated August 10, 2026.
- Wachtell, Lipton, Rosen & Katz provided a validity opinion on the notes.
- Certain portions of the underwriting agreement were omitted as confidential and non-material under Regulation S-K.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events On August 12, 2026, The Charles Schwab Corporation (“CSC”) issued $1,250,000,000 aggregate principal amount of 5.108% Fixed-to-Floating Rate Senior Notes due 2032 (the “2032 Notes”) and $1,350,000,000 aggregate principal amount of 5.655% Fixed-to-Floating Rate Senior Notes due 2037 (the “2037 Notes” and, together with the 2032 Notes, the “Notes”). The net proceeds of the offering of the Notes were approximately $2,582 million after deducting underwriting discounts and commissions and estimated offering expenses. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.